Sio Capital Management’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Sio Capital Management’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,102	Closed	-$516K	–	63
2024 Q1	$516K	Hold	5,102	–	–	0.15%	45
2023 Q4	$120K	Hold	5,102	–	–	0.03%	40
2023 Q3	$103K	Hold	5,102	–	–	0.03%	48
2023 Q2	$133K	Hold	5,102	–	–	0.03%	41
2023 Q1	$106K	Hold	5,102	–	–	0.05%	40
2022 Q4	$104K	Hold	5,102	–	–	0.04%	43
2022 Q3	$141K	Hold	5,102	–	–	0.04%	42
2022 Q2	$135K	Hold	5,102	–	–	0.05%	56
2022 Q1	$408K	Hold	5,102	–	–	0.14%	54
2021 Q4	$1.04M	Hold	5,102	–	–	0.31%	55
2021 Q3	$1.65M	Sell	5,102 -1,944	-28%	-$567K	0.53%	46
2021 Q2	$1.83M	Buy	7,046 +1,796	+34%	+$547K	0.45%	58
2021 Q1	$2.03M	Sell	5,250 -2,245	-30%	-$906K	0.41%	63
2020 Q4	$3.13M	Buy	+7,495	New	+$2.36M	0.64%	54

Other funds holding VINC

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

SRC

Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sio Capital Management's VINC Position: Q2 2024 in Review

Sio Capital Management sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q2 2024, closing a stake of 5,102 shares — an estimated $516K sold.

Sio Capital Management first reported a position in VINC in Q4 2020 and held it in 14 quarters. The position peaked at $3.13M in Q4 2020. 27 funds tracked by Wall St. Rank hold VINC as of Q2 2024.

Sio Capital Management reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Sio Capital Management sold 5,102 Vincerx Pharma, Inc. Common Stock shares in Q2 2024, an estimated $516K.
Sio Capital Management first reported a position in Vincerx Pharma, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
Sio Capital Management's Vincerx Pharma, Inc. Common Stock position peaked at $3.13M in Q4 2020.
27 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q2 2024.

Based on Sio Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.